Friday Market Pulse: Major Analyst Upgrades, Initiations, and Key Ratings Across Tech, Space, and Consumer Sectors

Wall Street analysts delivered a busy session of upgrades, downgrades, and fresh initiations on Friday, spanning key movers across the technology, automotive, space, healthcare, and retail sectors. From artificial intelligence leaders to homebuilders and autonomous driving pioneers, major firms shared their latest price targets and strategic outlooks on highly watched stocks.

Technology and AI: Nvidia, Microsoft, Apple, and Fox

In the technology space, Evercore ISI reiterated its buy rating on Nvidia (NVDA), staying the course despite recent stock underperformance relative to the S&P 500. The firm attributed recent softness to three key concerns—namely, fears that DeepSeek lowers overall AI demand, shifts AI compute cycles away from Nvidia, and potential Blackwell platform delays. However, Evercore’s channel checks dispute all three concerns, reinforcing their confidence in the chipmaker.

Meanwhile, Goldman Sachs kept a bullish stance on Microsoft (MSFT), reiterating a buy rating ahead of upcoming earnings. Goldman described Microsoft as the best-positioned name in its software coverage to benefit from compounding AI product cycles. Over at UBS, checks showed flat iPhone wait times for Apple (AAPL), with the firm reiterating a neutral rating. UBS Evidence Lab data tracking availability across over 30 geographies showed average wait times for the iPhone Pro shortened by roughly four days year-over-year, while the Pro Max remained relatively flat.

In the media and tech integration space, Bank of America upgraded Fox (FOXA) to buy from underperform, raising its price target to $85 from $54. The upgrade reflects a shifting risk/reward profile following the pending Roku acquisition, with the new target representing roughly 10 times the firm’s updated CY28E pro forma EV/EBITDA.

Space, Autos, and Telecom: SpaceX, Tesla, Mobileye, and EchoStar

Space and aviation stocks saw significant action. Evercore ISI reiterated SpaceX (SPCX) as outperform, raising its price target to $275 per share from $230. The firm noted expectations that the upcoming Q26 print will be judged less on quarterly revenue and EBITDA—where they are ahead of the Street—and more on five key debates driving medium-term estimates and sentiment through year-end and into 2027.

JPMorgan upgraded EchoStar (SATS) to overweight from underweight, reinstating coverage with a December 2027 price target of $144. The firm described the satellite services provider as attractive following a period of trading restrictions. Macquarie initiated coverage on Intuitive Machines (LUNR) with an outperform rating, praising its net cash balance sheet and its transformation into a vertically integrated space prime. The firm noted that LUNR offers exposure to increasing investment in recurring space operations and services.

On the automotive front, Morgan Stanley reiterated Tesla (TSLA) as equal weight, noting it is getting more “constructive” ahead of earnings. The firm highlighted that Tesla’s energy business remains underappreciated, with integrated storage, solar, and compute driving Tesla’s transition into an integrated distributed compute and power provider. Citi initiated coverage on Mobileye (MBLY) as a buy with an $11 price target, stating that the company is best positioned for autonomous driving. “Autonomous driving begins with vision, and Mobileye is the global leader with vehicle vision solutions,” the firm noted.

Healthcare, Biotech, and Life Sciences: Praxis, Revolution, Idexx, and Elanco

Analysts initiated coverage on several healthcare and biotech names. JPMorgan initiated Praxis Precision Medicines (PRAX) with an overweight rating and a December 2027 price target of $700, calling the company “unique.” William Blair initiated coverage on Revolution Medicines (RVMD) with an outperform rating, highlighting its dominant position and a DCF-based valuation of $226 per share.

Goldman Sachs initiated coverage on two animal health companies, rating both as buys. The firm highlighted Idexx Laboratories (IDXX) as a high-quality compounder with a proven execution track record, while describing Elanco (ELAN) as an innovation-driven turnaround story where the market underappreciates the growth runway from recent product cycles. Piper Sandler initiated iRhythm (IRTC) with an overweight rating and a $160 price target, encouraging investors to buy the dip. The target ascribes a roughly 4.5x EV/Sales multiple to the firm’s 2028 sales estimate. Jefferies initiated Concentra (CON) with a buy rating, citing a high-quality compounder profile with a differentiated ROIC of 11-13% compared to a peer average of 6-9%, a structurally advantaged payor mix, and a dominant position in occupational health.

Industrials, Housing, and Materials: Toll Brothers, Martin Marietta, Moog, and Greif

Homebuilders and materials companies received positive updates. StoneX initiated Toll Brothers (TOL) with a buy rating and a $165 per share price target, stating the luxury homebuilder is well-positioned despite broader housing market uncertainty. DA Davidson upgraded Martin Marietta Materials (MLM) to buy from neutral with a $610 price target, advising investors to buy the weakness.

In industrials, Morgan Stanley upgraded Moog (MOG) to overweight from equal weight, arguing that consensus is underestimating growth and earnings into next year, with the FY27 guide and December investor day serving as key catalysts. Raymond James upgraded Greif (GEF) to outperform from market perform, characterizing the company as a “self-help story.” Despite expectations of weak volumes, Greif’s self-help playbook continues to drive margin expansion. Roth upgraded Avino Silver (ASM) to buy from hold, noting shares have plenty of upside, though they lowered the price target from $8.00 to $7.00.

Consumer, Retail, and Semiconductors: Victoria’s Secret, Brinker, Capri, and Semtech

In the retail and consumer sector, Needham initiated Victoria’s Secret (VSXY) with a buy rating and a $106 price target, expressing bullish sentiment on the company’s turnaround. Raymond James upgraded Capri (CPRI) to strong buy from outperform on a favorable setup, and upgraded Brinker (EAT)—owner of Chili’s—to strong buy from outperform. The firm expects a strong beat and raise, seeing tangible levers to sustain mid-single-digit percentage comparable growth through menu, marketing, and operations.

Semiconductors also saw a major upgrade, with Northland upgrading Semtech (SMTC) to outperform from market perform. The firm noted that after a recent 24% share decline, the risk/reward and valuation are now much more attractive.

Source link